Location: Home
  • search
  • go
  • Relate News
  • 6/16/2022May Approvals Spotlight the Rise of Pediatric Drugs under Policy Suppo...
  • 6/15/2022Data Snapshot: Competitive Landscape of Chinese Biosimilars
  • 6/15/2022NMPA Holds Forum to Hear Feedbacks from Pharma MNCs
  • 6/15/2022NHSA Releases the Draft Working Plan and the Application Guide for Adj...
  • 6/14/2022IQVIA: Chinese Retail Pharmacy Sales Down 1.2% in Q1/2022
  • 6/14/2022NHSA Publishes 2021 National Basic Medical Insurance Sector Developmen...
  • 6/14/2022Pharma Giants Turn to Incubators to Tap Chinese Innovation and Hatch S...
  • 6/14/2022Lawmakers Make Bipartisan Push for New Government Powers to Block U.S....
  • 6/14/2022FDA's Treatment of China-Developed Drugs Spurs Demands for Multiregion...
  • 6/13/2022How American Companies are Approaching China's Data, Privacy, and Cybe...
  • 6/13/2022Organon Enters Licensing Deal with Chinese Biotech Henlius for Biosimi...
  • 6/13/2022Gavi: Chinese Vaccine to Play Major Role in Future Health Challenges
  • 6/10/2022NHC and SATCM Issue the Rules for Internet Diagnosis and Treatment Reg...
  • 6/10/2022Drug R&D and Product Registration News Digest June 2022 (1)
  • 6/10/2022Delisting Risk, Souring Relations Are Hurdles for Chinese Biotech Firm...
  • 6/9/2022OnCusp and Multitude Enter into an Ex-China Licensing Agreement for a ...
  • 6/8/2022Nicholas Hall Reports Improved Chinese OTC GI Market Growth for 2021 B...
  • 6/7/2022Nicholas Hall Group: Performance of China's Consumer Healthcare Market...
  • 6/7/2022NH's DB6: Top Ten Chinese CHC Brands in 2021
  • 6/7/2022NH's DB6: Chinese OTC Drug Market Forecast 2026/2031
  • 6/7/2022CanSino and Pfizer Terminate vaccine deal
  • 6/7/2022Fosun Pharma Acquires 60% of Singapore OncoCare Medical for $158M
  • 6/7/2022China Issues the Notice on Correction of Irregularities in Drug Procur...
  • 6/7/2022How Shanghai Kept Clinical Trials Going During Lockdown (PharmaDJ)
  • 6/6/2022CDE Issues the Statistical Guidelines for Clinical Research of Rare Di...
  • 6/6/2022Pfizer/CStone Cejemly Gets China Approval for Expanded Use in Advanced...
  • 6/6/2022Kexing Soars After Signing Salubris to Develop, Make Oral Covid-19 Dru...
  • 6/6/2022WuXi Biologics Launches First Commercial Drug Product Facility for Pre...
  • 6/6/2022China Issues the 14th Five-Year National Health Plan with A New Focus ...
  • 6/3/2022NeoGenomics's Suzhou Pharma Services Lab Gets CAP Certification
  • Page:152/789 Total number of articles:23668: [First][<<] [150] [151] [152] [153] [154] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group